Molecular/biomarker testing in lung cytology: A practical approach
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.25054
Abstract: The increasing comprehension of molecular mechanisms underlying lung cancer and the discovery of targetable genomic alterations has dramatically change the pathological approach to lung cancer, especially non‐small cell lung cancer (NSCLC). This unstoppable knowledge has… read more here.
Keywords: lung cancer; molecular biomarker; lung; cytology ... See more keywords
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Haematology"
DOI: 10.1111/ejh.13755
Abstract: Molecular biomarker tests can inform the clinical management of genomic heterogeneous hematological malignancies, yet their availability in routine care largely depends on the supporting health economic evidence. This study aims to systematically review the economic… read more here.
Keywords: molecular biomarker; biomarker tests; hematological malignancies; economic evidence ... See more keywords
Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
Sign Up to like & getrecommendations! Published in 2019 at "BMC Urology"
DOI: 10.1186/s12894-019-0561-6
Abstract: BackgroundIdentifying men for a repeat prostate biopsy is a conundrum to urologists. Risk calculators (RCs) such as the European Randomized Study of Screening for Prostate Cancer (ERSPC) RCs have been developed to predict the outcome… read more here.
Keywords: prostate; molecular biomarker; risk; biomarker ... See more keywords
The use of molecular biomarker tests: an interview study with healthcare providers about a molecular biomarker test for prostate cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Personalized medicine"
DOI: 10.2217/pme-2020-0156
Abstract: Aim: Investigate why healthcare providers are not always willing to use molecular biomarker tests, even though they promise to personalize disease diagnosis and treatment. Materials & methods: We interviewed 20 Dutch urological healthcare providers to… read more here.
Keywords: molecular biomarker; healthcare providers; use; biomarker ... See more keywords
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.855674
Abstract: The drug 5-fluorouracil (5-Fu) is the critical composition of colorectal cancer (CRC) treatments. Prognostic and predictive molecular biomarkers for CRC patients (CRCpts) treated with 5-Fu-based chemotherapy can provide assistance for tailoring treatment approach. Here, we… read more here.
Keywords: drug; molecular biomarker; resistance; colorectal cancer ... See more keywords